Notice of Postal Ballot
Cadila Healthcare Ltd has informed BSE that the members of the Company will consider to approve the resolutions, by way of Postal Ballot.13-04-2015
13-04-2015
Company news
The board of directors of Cadila Healthcare on Wednesday decided to obtain enabling approval from shareholders through postal ballot to raise up to 10,000 crore. The funds will be raised t...08-04-2015
Outcome of Board Meeting
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 08, 2015, has been decided to obtain enabling approval of the shareholders' of the Company through postal ballot process for issuance of the following securities.1. Equity Shares including Convertible Bonds/Debenture through Qualified Institutional Placement (QIP) and/or Depository Receipts or any other modes for an amount not exceeding Rs 10,000 Crores; and...08-04-2015
Shareholding Pattern For March 31, 2015
Cadila Healthcare Ltd has informed BSE about the Shareholding Pattern as on March 31, 2015.08-04-2015
Updates
Cadila Healthcare Ltd has informed BSE that the Company has purchased 50% shares of Zydus BSV Pharma Private Limited (Zydus BSV) from Bharat Serums and Vaccines Limited and now Zydus BSV has become 100% subsidiary of Cadila Healthcare Limited.26-03-2015
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Cadila Healthcare Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199219-03-2015
Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Ganesh N Nayak has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 199218-03-2015
Zydus launches SoviHep - the breakthrough therapy for Hepatitis C in alliance with Gilead Sciences
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated March 17, 2015 titled "Zydus launches SoviHep - the breakthrough therapy for Hepatitis C in alliance with Gilead Sciences"17-03-2015
Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Nitin R Desai has submitted the disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 199209-03-2015
Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Cadila Healthcare Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 199207-03-2015